Soft tissue sarcoma is a rare type of cancer that develops in the body’s soft tissues, such as fat, muscle, nerves, tendons, and blood or lymph vessels. It can occur anywhere in the body, but nearly 40% of cases are found in the arms and legs.
Melanoma is the most dangerous form of skin cancer. It develops when DNA damage—usually from ultraviolet (UV) radiation from the sun or tanning beds—causes mutations in skin cells. These damaged cells multiply rapidly, forming malignant tumors that begin in melanocytes (the pigment-producing cells of the skin).
Melanomas often look like moles, and some even develop from existing moles. While most are black or brown, melanomas can also appear pink, red, purple, blue, white, or skin-colored.
Our surgeons, oncologists, radiologists, and pathologists use a multidisciplinary approach (MDT) to confirm diagnosis and determine the stage of disease. This may involve a physical exam, imaging tests, or a biopsy. Depending on the stage, treatment may include surgery, chemotherapy, immunotherapy, radiation therapy, or multimodality combination therapy. Advanced options like HIPEC and Limb Infusion with Targeted Immunotherapy are also available.
Risk Factors: Certain inherited conditions like neurofibromatosis, Gardner’s syndrome, Li-Fraumeni syndrome, and retinoblastoma increase risk. Some types are more common by age group—for example, rhabdomyosarcoma in children, and synovial sarcoma in adolescents. Most cases, however, occur without a clear cause.
Our team will guide patients and families step by step through all stages of diagnosis and treatment to achieve results based on international guidelines and benchmarks.